Liangjun Zhu M.M.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma (NCT05237349) | Liangjun Zhu M.M. | 2022-03-01 |
Track Liangjun Zhu M.M. automatically
Every clearance here is in the API, with alerts when new ones post.